Flavokawains are chalcones that can be found in the root extracts of the kava-kava (Piper methysticum) plant. Flavokawain A and flavokawain B are known to possess potential anti-inflammation and anti-cancer activities. Nevertheless, the effects of both these compounds on the normal function of the host have not been studied. There is a need to find agents that can enhance the functionality of the immune system without disturbing the homeostatic balance. This study aimed to determine the toxicity and immunomodulatory effects of flavokawain A and flavokawain B on Balb/c mice. Several assays were conducted, the MTT viability assay, cytokine detection (IL-2 and TNF-), immunophenotyping of important immune markers, serum biochemical analysis and detection of nitric oxide levels. Based on our results, flavokawain A and B did not cause mortality and all mice were observed normal after the treatment period. Both flavokawains stimulated splenocyte proliferation, the secretion of IL-2 and TNF-α and raised the population of T cell subsets without significantly altering the level of several serum biochemical parameters. Overall, flavokawain A and B could serve as potential immune-modulator drugs without causing any toxicity, however further in vivo evidence is needed.
Kava-kava, Piper methysticum, is a common plant that is consumed in the Pacific regions [1a] . The extract of the roots of thisplantare used as a relaxing agent or a sedative [1a] . There are two types of classes of molecules that can be found in the root extract: kavalactones and chalcones [1b,c] . Chalcones are precursors of flavonoids and are involved in various biological activities such as anti-inflammatory, anti-oxidant and anti-tumorigenicactivities [1c] . There are three types of chalcones that can be identified in the kavakava root extracts; flavokawain A, flavokawain B and flavokawain C, with flavokawain C being the least abundant [1b] . In terms of theirmolecular structures, flavokawain A and flavokawain B have similar backbones except for the side chain [1c] . Both of these chalcones also possess similar anti-cancer and anti-inflammatory activities [1c] . Even though, flavokawain A and B have a vast potential in regulating several biological activities, the administration of foreign substances should not be toxic towards the host. Also, the functions of important organs such as liver, heart and kidney should not be interfered with when administrating these agents [2a] . Additionally, our society is exposed to numerous diseases due to diet, environmental and lifestyle factors. To boost our defense mechanism against these ailments, supplementary agents that enhance the immune system are widely explored [2a] . In times of need, the immune system sometimes require support to fully function at a higher level of defense [2a] . These immunomodulating agents should boost certain important immune players while still maintaining the homeostasis within the body. Naturally derived supplements have accounted for a wide selection of immunomodulating agents such as curcumin, quercetin and gensitein [2b]. The safety profiles of flavokawain A and B, however, have not been fully explored. By orally administrating these compounds for several consecutive days, we aim to elucidate whether these compounds have any adverse toxic effects. Additionally, in terms of the immune modulation potential, a comparison between flavokawain A and B is still unknown. Therefore, the aim of this study was to investigate and compare the toxicity and immunomodulatory effects of flavokawain A and flavokawain B in a murine model.
Besides modulating the immune system, the administration of flavokawain A and flavokawain B should not induce any stress or toxic response in the host. Based on Table 1 , the effects of flavokawain A and B on the mortality rate, as well as body weight changes were observed. There were no significant changes in the body weight of the mice, and there were no apparent toxic signs observed for 28 days. All of the mice treated with flavokawain A and B survived the treatment at 28 days. These observations indicated that flavokawain A and flavokawain B do not appear to be toxic. The introduction of a foreign substance should not affect vital organs such as the kidney and liver. Based on Table 1 , the serum biochemical analysis was done in all of the groups. The level of serum albumin slightly decreased in the flavokawain A and flavokawain B treatment groups. Albumin is an important carrier protein in the blood and plasma that carries nutrients and hormones vital for the body [3] . Serum levels of ALT, AST and ALP are important indicators of any hepatic injury in the host. According to Table 1 , there was an increase in the ALT level of flavokawain A-treated mice, although this value decreased in the flavokawain B-treated mice. Nevertheless, the level of AST decreased on both treatments, whereas the level of ALP elevated. These data indicate that while there are slight changes in the level of these markers, there were no significant alterations observed. The level of creatinine in the serum is a common marker of the functional health of the kidney [4,5a] . Creatinine is commonly interpreted as a measure of the glomerular filtration rate (GFR) [5a] . There were no significant changes in the level of serum creatinine in the flavokawain A and flavokawain B treated mice indicating that both compounds did not impede any renal function.
To determine the effects of flavokawain A and flavokawain B on the proliferation of splenocytes harvested from mice, the MTT assay was conducted. According to Figure 1 , the percentage of splenocyte viability increased upon treatment withflavokawain B in a dosedependent manner from 100±2.1% in the control group to 137.5±0.1% and 140.8±2.2% in the 15 µg/mL and 30 µg/mL groups, respectively. In the flavokawainA treatment group, the percentage of viability decreased to 92.9±7.2 and 90.4±4.3% in the 15 µg/mL and 30 µg/mL groups. Based on these results, it can be suggested that flavokawain B induced the proliferation of splenocytes at a higher level than flavokawain A. Though flavokawain A did not enhance the proliferative state of splenocytes, it also did not induce any significant toxicity.
Besides the MTT assay, the secretion of two cytokines IL-2 and TNF- was also measured in the splenocytes upon treatment with flavokawain A and flavokawain B. The level of TNF- declined substantially in the flavokawain A and B treated splenocytes as depicted in Figure 2 . In the flavokawain A treated group this valuedecreased from 147.4±3.9 pg/mL to 128.8±2.0pg/mL in the 15 µg/mL group and 97.4±1.0pg/mL in the 30 µg/mL treatment group. Whereas, in the flavokawain B treatment group, the level of TNF- decreased to 44.1±2.2 pg/mL and 12.1±2.9pg/mL in the 15 µg/mL and 30 µg/mL treatment groups, respectively. TNF- is known to have conflicting roles in the regulation of the immune system [5b]. TNF-α is commonly known to be associated with the response against pathogenic infections [5c]. Nevertheless, the expression of TNF-α is also related to other kinds of illnesses and diseases by promoting inflammation [5b]. TNF-α contributes to the progression of inflammatory-related rheumatoid arthritis, ankylosing spondylitis, cardiovascular and renal diseases [5b]. Additionally, in the NO detection assay, the level of nitric oxide declined in the flavokawain A and flavokawain B treatment splenocytes. Figure 3 . Nitric oxide is known to influence a variety of immune-related mediators. Nevertheless, the effects of NO is not specific, it can defend the host against toxic substances while also increase the inflammatory response [5d]. NO is a vital player in the pathogenesis of inflammatory-related diseases [6] . Therefore, substances that can inhibit nitric oxide possess therapeutic value [6] .
The level of the cytokine IL-2 was also measured in the supernatant of the cytokines. Interestingly, in flavokawain A-treated splenocytes the level of IL-2 decreased marginally from 7.8±1.0 pg/mL to 6.8±4.3pg/mL in the 15µg/mL treatment group and 6.3±0.2pg/mL in the 30µg/mL treatment group. Meanwhile, in the flavokawain B treated group, the level of IL-2 increased subtly to 9.0±0.6pg/mL in the 15µg/mL group and 10.1±0.1pg/mL in the 30µg/mL treatment group. By increasing the level of IL-2, the regulation of immune system is increased and also homeostasis in the body is further established [7] . Between the two compounds, flavokawain B managed to elevate the levels of IL-2 more than 1.6 fold change 
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Natural Product Communications Vol. 10 (7) 2015 1201 compared to that of flavokawain A as illustrated in Figure 2 . This suggests that flavokawain B is plausibly better in strengthening the immune system through the regulation of IL-2 cytokine; nevertheless further in vivo evidence is needed. An in vivo model was used to determine the effects of consuming flavokawain A and flavokawain B. The harvested splenocytes from all groups were subjected to staining with five different immune markers: CD4, CD8, CD3 and macrophage. Based on Figure 3 , the levels of theCD4+/CD3+ cell population increased from 14.0±0.2% in the control group to 17.6±0.2% in flavokawain A-treated splenocytes and 34.4±0.8% in the flavokawain B-treated splenocytes. Apart from that, the percentage of CD8/CD3 population also increased in the treatment group, and similar to thepattern seen in the CD4/CD3 population, flavokawain B increased the percentage of CD8/CD3 cell population at a higher rate than that of flavokawain A. As seen in Figure 4 . CD8 cells on the other hand are commonly associated with cytotoxic activity. Moreover, CD8 cells perform cytotoxic actions in two main ways; by perforin and granzyme [9] . Nevertheless, the release of certain cytokines also facilitates these actions. CD8 cells are essential in the line of defense against various infections and eradication of infected cells [9] . Additionally, we also measured the level of M2 phenotype macrophages in splenocytes harvested from all groups. In the control group, the percentage of the M2 phenotype is 11.6±0.1%, in the flavokawain A-treated splenocytes the percentage is 8.9±0.1%, and in the flavokawain B-treated splenocytes, this value also decreased to 2.2±0.2%. The polarization of the macrophages to the M2 phenotype is associated with several chronic diseases such as breast cancer, fibrosis and asthma [10] .
There are therapeutic advances in understanding the effects of polarization of macrophages in the immune system as it is still a poorly understood area [10, 11] . Based on our findings, flavokawain B regulated the immune system at a more significant level than flavokawain A and both of these treatments did not significantly altered the body weight and serum biochemical profile of the mice. All in all, our data suggests that both flavokawain A and flavokawain B may have the potential as an immunomodulatory agent as well as participate in other biological activities such as anti-cancer and anti-inflammatory without inducing any toxic stress.
Experimental

Flavokawain A and B preparation:
Both pure flavokawain A and B compounds were obtained from Dr. Nadeem Akhtar, Universiti Malaysia Pahang. Flavokawain A and B were synthesized according to Mohamad et al. [12] .
Animals: 8-weeks old, male BALB/c mice were obtained from the animal house, Monash University, Malaysia (Subang Jaya, Malaysia). The mice were randomly selected and grouped into 3 mice per group, control, flavokawain A and flavokawain B. The mice were accommodated under standard conditions as outlined by the Universiti Putra Malaysia ethics committee guidelines. All of the mice were kept at 25±2 o C on a regular 12-hour dark-light cycle and were fed with tap water and standard diet pellets. This study was conducted in compliance with the Universiti Putra Malaysia's ethical guidelines.
In vitro Splenocytes Viability Assay (MTT assay):
Spleens obtained from mice were washed three times with ice-cold PBS. Afterwards the spleens were lysed using a lysis buffer (90g NH 4 Cl, 10 g KHCO 3 , and 370 mg EDTA) until all of the red blood cells were removed. Then, 2x106 cells/mL of the splenocytes were seeded in a 96 well plate. Subsequently, the cells were treated with seven different concentrations of flavokawain A and flavokawain B for 24 hours. The cells were kept in a 37 o C incubator equipped with 5% CO 2 for 24 hours. 
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solution (Calbiochem, USA) (5 mg/mL) was added to the cells and was incubated for 4 hours. Next, the plate was spun down at 1000 rpm for 5 minutes. The upper solution was removed and 100 µL of DMSO (Fisher Scientific, USA) was added to solubilize the crystals. Then, the plate was read at 570 nm using the µquant microplate reader (Bio-tek Instruments, USA). The percentage of cell viability was calculated based on the following formula:
Percentage of Splenocyte viability = (Absorbance at 570 nm of sample/Absorbance at 570 nm of control) *100%
In vitro Splenocytes Secretion of IL-2, TNF-α and NO:
The presence of IL-2 and TNF-α in the splenocytes treated with flavokawain A and flavokawain B were detected. The ELISA MAX TM Sets were employed (BioLegend, USA) according to the user guide provided. Prior to the experiment, 96-well plates were coated with the diluted capture antibody overnight at 4 o C. The plates were washed four times with PBS-0.05% Tween 20, before being blocked for 1 hour at room temperature. Afterwards, the plates were washed and the standard dilutions as well as the samples were added and incubated for 2 hours. After the incubation time, the plates were washed four times, then, the diluted detection antibody was added to the wells and incubated for 1 hour. Next, the diluted avidin-HRP was added for 30 minutes at room temperature. Afterwards, the TMB substrate solution was added until the desired color develops. At the end of the assay, the stop solution was added to each well before being read at 450 nm and 570 nm using the µquant microplate reader (Bio-Tek Instruments, USA).
Animal Treatment:
The experiment began one week after obtaining the mice, allowing the mice to adapt to the laboratory environment. The treatment of 50 mg/kg/day of flavokawain A and flavokawain B were administered orally for 28 days. This dose was selected based on a previous cancer study [13] . This study was conducted in compliance with the Universiti Putra Malaysia's ethical guidelines.
Serum Biochemical Analysis:
Blood was obtained from the sacrificed mice by cardiac puncture and the serum was obtained by centrifugation. Next, the serum was subjected to biochemical analysis. The level of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), creatinine, and albumin, in mice serum were determined by standard assay kits (Roche Diagnostic GmbH, USA) and analyzed using 902 Hitachi automatic analyser (Hitachi LTD, Japan).
In vivo Splenocytes Immunophenotyping: Splenocytes obtained from the sacrificed mice were quickly rinsed in ice-cold PBS and meshed through a 70µM sterile wire mesh with a rubber syringe plunger. The cell suspension was then washed with PBS and centrifuged at 2000 rpm for 5 minutes. Next, the red blood cells were lysed and removed by incubating the cell suspension in a lysis buffer for 10 minutes at 4 o C. After the incubation time, PBS was added to the suspension and the mixture was spin down at 2000 rpm for 5 minutes. Then, the cells were washed again with PBS-BSA before being subjected to cell counting analysis. Around 1x10 6 cells werestained with the designated fluorochrome-conjugated antibodies (Abcam, USA) for 2 hours. Then, the cells were fixed in 4% paraformaldehyde (Sigma, USA) and stored in 4 o C before being subjected to flow cytometer analysis (FACS Calibur, BD, USA).
In vivo Nitric Oxide Detection of the Spleen:
To detect the level of nitric oxide, the Griess reagent kit (Sigma, USA) was used according to the user's manual. The harvested splenocytes were mixed with the Griess reagent and deionized water before being incubated for 30 minutes at room temperature. Afterwards the absorbance of the mixture was measured at 548 nm using the µquant microplate reader (Beckman Coulter, USA)
Statistical Analysis: All experiments were done in triplicate and the average values were obtained. The statistical analysis was performed using the GraphPad Prism (version 4.0) with the significance set at p<0.05.
